Association of Sub-Threshold Amyloid Retention With Neuropsychological Performance in Cognitively Normal Older Adults Without the APOE ε4 Allele

키워드

참고문헌 (50)

1. "Global action plan on the public health response to dementia 2017–2025"[URL]
2. World Alzheimer Report 2015. The global impact of dementia: an analysis of prevalence, incidence, cost and trends, "Prince M", Alzheimer’s Disease International, ~ (2015)
3. Sperling R, "The evolution of preclinical Alzheimer’s disease : implications for prevention trials", Neuron, 84, pp.608~622 (2014)
4. Twamley EW, "Neuropsychological and neuroimaging changes in preclinical Alzheimer’s disease", J Int Neuropsychol Soc, 12, pp.707~735 (2006)
5. Sperling RA, "Preclinical Alzheimer disease—the challenges ahead", Nat Rev Neurol, 9, pp.54~58 (2013)
6. Jack Jr CR, "NIA-AA research framework : toward a biological definition of Alzheimer’s disease", Alzheimers Dement, 14, pp.535~562 (2018)
7. Hanseeuw BJ, "Association of amyloid and tau with cognition in preclinical Alzheimer disease : a longitudinal study", JAMA neurology, 76, pp.915~924 (2019)
8. Chételat G, "Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer’s disease", Neuroimage Clin, 2, pp.356~365 (2013)
9. Carey CL, "Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly", Stroke, 39, pp.397~402 (2008)
10. Landau SM, "Memory decline accompanies subthreshold amyloid accumulation", Neurology, 90, pp.e1452~e1460 (2018)
11. Bischof GN, "Subthreshold amyloid and its biological and clinical meaning : long way ahead", Neurology, 93, pp.72~79 (2019)
12. Cho H, "In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum", Ann Neurol, 80, pp.247~258 (2016)
13. Farrell ME, "Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults", Neurology, 91, pp.e1809~e1821 (2018)
14. Farrell ME, "Defining the lowest threshold for amyloid-PET to predict future cognitive decline and amyloid accumulation", Neurology, 96, pp.e619~e631 (2021)
15. Steenland K, "Biomarkers for predicting cognitive decline in those with normal cognition", J Alzheimers Dis, 40, pp.587~594 (2014)
16. Fouquet M, "Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan", Neuropsychol Rev, 24, pp.290~299 (2014)
17. Montagne A, "APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline", Nature, 581, pp.71~76 (2020)
18. Liu CC, "Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy", Nat Rev Neurol, 9, pp.106~118 (2013)
19. Lee JH, "Development of the Korean Version of the Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet(CERAD-K) : clinical and neuropsychological assessment batteries", J Gerontol B Psychol Sci Soc Sci, 57, pp.47~53 (2002)
20. Park JH, "Standardization of Korean version of the Mini-Mental State Examination (MMSE-K) for use in the elderly. Part II. Diagnostic validity", J Korean Neuropsychiatr Assoc, 28, pp.508~513 (1989)
21. Thurfjell L, "Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid : concordance with visual image reads", J Nucl Med, 55, pp.1623~1628 (2014)
22. Smith SM, "Advances in functional and structural MR image analysis and implementation as FSL", Neuroimage, 23(Suppl 1), pp.S208~S219 (2004)
23. Smith SM, "Fast robust automated brain extraction", Human Brain Mapp, 17, pp.143~155 (2002)
24. Zacharaki EI, "Measuring brain lesion progression with a supervised tissue classification system", Med Image Comput Comput Assist Interv, 11, pp.620~627 (2008)
25. Ardekani BA, "Quantitative comparison of algorithms for intersubject registration of 3D volumetric brain MRI scans", J Neurosci Methods, 142, pp.67~76 (2005)
26. Tzourio-Mazoyer N, "Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain", Neuroimage, 15, pp.273~289 (2002)
27. Choi WH, "Automated quantification of amyloid positron emission tomography : a comparison of PMOD and MIMneuro", Ann Nucl Med, 30, pp.682~689 (2016)
28. flutemetamol β-amyloid PET brain images, "Nucl Med Commun", 2017, 234~241
29. Villemagne VL, "Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study", Lancet Neurol, 12, pp.357~367 (2013)
30. Doraiswamy PM, "Florbetapir F 18 amyloid PET and 36-month cognitive decline : a prospective multicenter study", Mol Psychiatry, 19, pp.1044~1051 (2014)
31. Lim YY, "Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer’s disease", Brain, 137, pp.221~231 (2014)
32. Small GW, "Prediction of cognitive decline by positron emission tomography of brain amyloid and tau", Arch Neurol, 69, pp.215~222 (2012)
33. Palmqvist S, "Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity", Nat Commun, 8, pp.1214~ (2017)
34. Sperling RA, "Amyloid deposition is associated with impaired default network function in older persons without dementia", Neuron, 63, pp.178~188 (2009)
35. Li X, "Neuronal activity and secreted amyloid β lead to altered amyloid β precursor protein and presenilin 1 interactions", Neurobiol Dis, 50, pp.127~134 (2013)
36. Sperling RA, "The impact of amyloid-beta and tau on prospective cognitive decline in older individuals", Ann Neurol, 85, pp.181~193 (2019)
37. flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease : specific detection of advanced phases of amyloid-β pathology, "Alzheimers Dement", 2015, 975~985
38. Ossenkoppele R, "Amyloid burden and metabolic function in early-onset Alzheimer’s disease : parietal lobe involvement", Brain, 135, pp.2115~2125 (2012)
39. Soman SM, "Does resting state functional connectivity differ between mild cognitive impairment and early Alzheimer’s dementia?", J Neurol Sci, 418, pp.117093~ (2020)
40. Rawle MJ, "Apolipoprotein-E(Apoe)ε4 and cognitive decline over the adult life course", Transl Psychiatry, 8, pp.18~ (2018)
41. Risacher SL, "The role of apolipoprotein E(APOE)genotype in early mild cognitive impairment(E-MCI)", Front Aging Neurosci, 5, pp.11~ (2013)
42. Pike KE, "Cognition and beta-amyloid in preclinical Alzheimer’s disease : data from the AIBL study", Neuropsychologia, 49, pp.2384~2390 (2011)
43. Murray ME, "Functional impact of white matter hyperintensities in cognitively normal elderly subjects", Arch Neurol, 67, pp.1379~1385 (2010)
44. Hedden T, "Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults", J Neurosci, 32, pp.16233~16242 (2012)
45. Dickerson B, "Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults", Neurology, 76, pp.1395~1402 (2011)
46. He J, "Influence of functional connectivity and structural MRI measures on episodic memory", Neurobiol Aging, 33, pp.2612~2620 (2012)
47. Scahill RI, "A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging", Arch Neurol, 60, pp.989~994 (2003)
48. Leal SL, "Subthreshold amyloid predicts tau deposition in aging", J Neurosci, 38, pp.4482~4489 (2018)
49. Jack CR Jr, "Tracking pathophysiological processes in Alzheimer’s disease : an updated hypothetical model of dynamic biomarkers", Lancet Neurol, 12, pp.207~216 (2013)
50. Farrell ME, "Association of longitudinal cognitive decline with amyloid burden in middle-aged and older adults : evidence for a doseresponse relationship", JAMA Neurol, 74, pp.830~838 (2017)

관련 논문AI추천